 |
2ak4D01 |
90.75 |
Homo sapiensT-cell receptor alpha chain C region |
2.60.40.10 |
114 |
32 |
90 |
1.41 |
1.56 |
 |
2ialA01 |
90.72 |
Homo sapiensT-cell receptor alpha chain C region |
2.60.40.10 |
108 |
29 |
93 |
1.55 |
1.66 |
 |
1u3hA00 |
90.05 |
Mus musculusTRAV14-3 |
2.60.40.10 |
110 |
34 |
92 |
1.49 |
1.61 |
 |
1kgcD01 |
88.53 |
Homo sapiensT-cell receptor alpha chain C region |
2.60.40.10 |
111 |
25 |
90 |
1.94 |
2.13 |
 |
1lp9E01 |
88.51 |
|
2.60.40.10 |
113 |
38 |
91 |
1.69 |
1.85 |
 |
2q8bH01 |
88.44 |
|
2.60.40.10 |
112 |
19 |
88 |
2.07 |
2.34 |
 |
1ogaE01 |
88.35 |
T-cell receptor beta-1 chain C regionHomo sapiensProtein binding |
2.60.40.10 |
111 |
25 |
90 |
2.41 |
2.68 |
 |
1kgcE01 |
88.34 |
T-cell receptor beta-1 chain C regionHomo sapiensProtein binding |
2.60.40.10 |
112 |
33 |
89 |
2.65 |
2.97 |
 |
1mjuH01 |
88.01 |
|
2.60.40.10 |
115 |
19 |
89 |
2.24 |
2.50 |
 |
1oaqL00 |
87.93 |
|
2.60.40.10 |
110 |
27 |
88 |
2.71 |
3.07 |
 |
1pewA00 |
87.91 |
Ig lambda chain V-VI region SUTHomo sapiens |
2.60.40.10 |
108 |
28 |
88 |
2.27 |
2.55 |
 |
1x9qA01 |
87.52 |
|
2.60.40.10 |
111 |
27 |
84 |
2.37 |
2.80 |
 |
2vxtH01 |
87.38 |
|
2.60.40.10 |
113 |
17 |
88 |
2.26 |
2.55 |
 |
1tvdA00 |
87.18 |
Homo sapiensHDV103S1 |
2.60.40.10 |
116 |
29 |
88 |
2.02 |
2.27 |
 |
2otuA00 |
87.11 |
|
2.60.40.10 |
115 |
27 |
86 |
2.33 |
2.71 |
 |
1yc7A00 |
86.81 |
|
2.60.40.10 |
116 |
23 |
87 |
2.36 |
2.68 |
 |
2aepL01 |
86.78 |
|
2.60.40.10 |
119 |
25 |
81 |
2.46 |
3.02 |
 |
2v44A01 |
86.71 |
Prion diseasesNeural cell adhesion moleculeNeuron cell-cell adhesionPlasma membraneNeural cell adhesion molecule 2 |
2.60.40.10 |
94 |
11 |
83 |
2.30 |
2.75 |
 |
3bp6A00 |
86.60 |
Mus musculusExternal side of plasma membraneProgrammed cell death protein 1Programmed cell death protein 1T cell receptor signaling pathway |
2.60.40.10 |
111 |
15 |
90 |
2.45 |
2.69 |
 |
1hxmB01 |
86.59 |
Homo sapiensT-cell receptor gamma-2 chain C region |
2.60.40.10 |
125 |
28 |
82 |
2.25 |
2.73 |
 |
2ij0C00 |
86.42 |
Homo sapiensT cell receptor beta variable 20/OR9-2 |
2.60.40.10 |
118 |
20 |
85 |
2.35 |
2.75 |
 |
1fo0B00 |
86.39 |
|
2.60.40.10 |
112 |
20 |
89 |
2.08 |
2.33 |
 |
1hkfA00 |
86.13 |
Integral to plasma membraneNatural cytotoxicity triggering receptor 2Cellular defense responseNatural killer cell mediated cytotoxicitySignal transduction |
2.60.40.10 |
108 |
11 |
91 |
2.69 |
2.93 |
 |
1mfaH01 |
86.10 |
|
2.60.40.10 |
97 |
14 |
82 |
2.33 |
2.82 |
 |
2rikA02 |
86.06 |
TitinOryctolagus cuniculus |
2.60.40.10 |
95 |
14 |
84 |
2.09 |
2.47 |
 |
1t2jA00 |
86.03 |
Homo sapiensSingle chain Fv |
2.60.40.10 |
116 |
20 |
88 |
3.23 |
3.64 |
 |
2j8hA01 |
85.97 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
97 |
13 |
85 |
2.19 |
2.56 |
 |
1smoB00 |
85.86 |
Receptor activityTriggering receptor expressed on myeloid cells 1Homo sapiensHumoral immune response |
2.60.40.10 |
110 |
17 |
89 |
2.50 |
2.81 |
 |
1fhgA00 |
85.86 |
TelokinMeleagris gallopavo |
2.60.40.10 |
102 |
14 |
85 |
2.17 |
2.54 |
 |
2j8hA02 |
85.82 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
98 |
15 |
84 |
2.38 |
2.82 |
 |
2q87C00 |
85.63 |
Homo sapiensCMRF35-like molecule 8CD300 antigen |
2.60.40.10 |
106 |
12 |
90 |
4.13 |
4.56 |
 |
1neuA00 |
85.54 |
Rattus norvegicusMyelin protein P0 |
2.60.40.10 |
115 |
12 |
86 |
2.57 |
2.96 |
 |
1qfoC00 |
85.49 |
Mus musculusSialoadhesinProtein binding |
2.60.40.10 |
114 |
17 |
89 |
3.96 |
4.43 |
 |
1hxmA01 |
85.40 |
|
2.60.40.10 |
121 |
20 |
82 |
2.35 |
2.84 |
 |
1xauA00 |
85.37 |
Integral to plasma membraneReceptor activityNegative regulation of B cell proliferationProtein bindingMus musculus |
2.60.40.10 |
104 |
10 |
89 |
2.63 |
2.94 |
 |
1qz1A03 |
85.31 |
Rattus norvegicusPrion diseasesNeural cell adhesion moleculePlasma membraneFibroblast growth factor receptor binding |
2.60.40.10 |
95 |
13 |
84 |
2.55 |
3.02 |
 |
1ypzF01 |
85.28 |
|
2.60.40.10 |
123 |
24 |
82 |
1.87 |
2.25 |
 |
2hp4A00 |
85.26 |
T-cell surface glycoprotein CD8 alpha chainCD8A antigen, alpha polypeptideHematopoietic cell lineagePrimary immunodeficiencyHomo sapiens |
2.60.40.10 |
112 |
19 |
89 |
2.54 |
2.84 |
 |
1bihA04 |
85.25 |
Hyalophora cecropiaHemolin |
2.60.40.10 |
88 |
18 |
76 |
2.31 |
3.01 |
 |
2ny1B01 |
85.18 |
Zinc ion bindingMaintenance of protein location in cellT-cell surface glycoprotein CD4Signal transductionT cell receptor signaling pathway |
2.60.40.10 |
98 |
17 |
85 |
2.93 |
3.43 |
 |
1g1cA00 |
85.02 |
Structural constituent of muscleCalcium ion bindingTelethonin bindingSarcomere organizationActin filament binding |
2.60.40.10 |
98 |
13 |
85 |
2.26 |
2.65 |
 |
3cafA01 |
84.98 |
Cell surfacePathways in cancerNucleusPositive regulation of cell proliferationFibroblast growth factor binding |
2.60.40.10 |
96 |
11 |
80 |
2.40 |
2.98 |
 |
2a38B01 |
84.82 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
99 |
10 |
86 |
2.95 |
3.41 |
 |
1nezH00 |
84.79 |
T-cell surface glycoprotein CD8 alpha chainProtein homodimerization activityHematopoietic cell lineageCD8A antigen, alpha polypeptideT cell receptor signaling pathway |
2.60.40.10 |
120 |
18 |
83 |
2.42 |
2.90 |
 |
2rikA03 |
84.78 |
TitinOryctolagus cuniculus |
2.60.40.10 |
92 |
11 |
84 |
2.37 |
2.81 |
 |
1f97A01 |
84.61 |
Mus musculusEpithelial cell differentiationJunctional adhesion molecule ACell adhesionTight junction |
2.60.40.10 |
102 |
14 |
92 |
3.99 |
4.33 |
 |
1cs6A04 |
84.61 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
90 |
14 |
80 |
2.32 |
2.88 |
 |
1gl4B00 |
84.58 |
Chondrocyte differentiationCardiac muscle tissue developmentCartilage development involved in endochondral bone morphogenesisProtein localizationBrain development |
2.60.40.10 |
89 |
19 |
78 |
2.37 |
3.01 |
 |
1dr9A01 |
84.38 |
Type I diabetes mellitusAutoimmune thyroid diseaseIntestinal immune network for IgA productionAllograft rejectionT-lymphocyte activation antigen CD80 |
2.60.40.10 |
105 |
10 |
84 |
3.55 |
4.19 |
 |
1ncwH01 |
84.28 |
|
2.60.40.10 |
119 |
20 |
86 |
2.67 |
3.08 |
 |
2v44A02 |
84.26 |
Prion diseasesNeural cell adhesion moleculePlasma membraneNeuron cell-cell adhesionNeural cell adhesion molecule 2 |
2.60.40.10 |
93 |
15 |
82 |
2.55 |
3.09 |
 |
1rhfA01 |
84.24 |
Integral to plasma membraneTyrosine-protein kinase receptor TYRO3Cell adhesionTYRO3 protein tyrosine kinase 3 [EC:2.7.10.1]Signal transduction |
2.60.40.10 |
89 |
15 |
78 |
3.09 |
3.93 |
 |
2bk8A00 |
84.20 |
Structural constituent of muscleCalcium ion bindingTelethonin bindingSarcomere organizationActin filament binding |
2.60.40.10 |
97 |
17 |
84 |
2.33 |
2.76 |
 |
1eajB00 |
84.20 |
Integral to plasma membraneReceptor activityCoxsackievirus and adenovirus receptorViral myocarditisCoxsackievirus and adenovirus receptor |
2.60.40.10 |
120 |
16 |
85 |
3.19 |
3.75 |
 |
2qsqB01 |
84.19 |
Carcinoembryonic antigen-related cell adhesion molecule 5Integral to plasma membraneHomo sapiensBasolateral plasma membrane |
2.60.40.10 |
108 |
15 |
88 |
3.69 |
4.15 |
 |
1koaA03 |
84.16 |
Caenorhabditis elegansProtein ZK617.1b, partially confirmed by transcript evidenceLocomotionReproduction |
2.60.40.10 |
96 |
13 |
84 |
2.20 |
2.60 |
 |
1vcaA01 |
83.85 |
Vascular cell adhesion protein 1MicrovillusPositive regulation of T cell proliferationHeterophilic cell-cell adhesionFilopodium |
2.60.40.10 |
89 |
15 |
80 |
2.82 |
3.50 |
 |
1cczA01 |
83.77 |
Homo sapiensLymphocyte function-associated antigen 3Protein binding |
2.60.40.10 |
93 |
10 |
82 |
3.27 |
3.96 |
 |
2ec8A04 |
83.68 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Extracellular spaceAcute myeloid leukemia |
2.60.40.10 |
100 |
13 |
82 |
2.35 |
2.85 |
 |
1bihA03 |
83.61 |
Hyalophora cecropiaHemolin |
2.60.40.10 |
100 |
14 |
84 |
2.95 |
3.49 |
 |
1cs6A01 |
83.55 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
105 |
16 |
83 |
2.76 |
3.29 |
 |
2cqvA00 |
83.49 |
Myosin light chain kinase activityProtein phosphorylationHomo sapiensMyosin light chain kinase, smooth muscle |
2.60.40.10 |
114 |
12 |
76 |
2.40 |
3.14 |
 |
1cs6A03 |
83.46 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
98 |
18 |
82 |
2.82 |
3.42 |
 |
1pkoA00 |
83.28 |
Rattus norvegicusMyelin-oligodendrocyte glycoproteinPositive regulation of MyD88-dependent toll-like receptor signaling pathway |
2.60.40.10 |
123 |
14 |
78 |
3.08 |
3.91 |
 |
2ec8A03 |
83.23 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Acute myeloid leukemiaProtein binding |
2.60.40.10 |
104 |
9 |
81 |
2.61 |
3.19 |
 |
1witA00 |
82.69 |
Caenorhabditis elegansProtein ZK617.1b, partially confirmed by transcript evidenceLocomotionReproduction |
2.60.40.10 |
93 |
9 |
83 |
2.66 |
3.19 |
 |
1cs6A02 |
82.69 |
Cell adhesion molecule bindingContactin 2Neuron cell-cell adhesionGallus gallusContactin-2 |
2.60.40.10 |
89 |
15 |
77 |
2.71 |
3.49 |
 |
1l6zA02 |
82.43 |
Mus musculusCarcinoembryonic antigen-related cell adhesion molecule 1 |
2.60.40.10 |
96 |
13 |
82 |
2.75 |
3.33 |
 |
1uctA01 |
82.41 |
Immunoglobulin alpha Fc receptorIntegral to plasma membraneCD89 antigenHomo sapiensImmune response |
2.60.40.10 |
91 |
8 |
80 |
2.83 |
3.51 |
 |
1ncnA00 |
82.32 |
T-lymphocyte activation antigen CD86Positive regulation of cell proliferationHomo sapiensImmune responseProtein binding |
2.60.40.10 |
110 |
18 |
81 |
3.18 |
3.89 |
 |
2gy5A02 |
82.22 |
Cell surfaceMicrovillusTransmembrane receptor protein tyrosine kinase signaling pathwayProtein bindingSignal transduction |
2.60.40.10 |
90 |
16 |
82 |
2.91 |
3.53 |
 |
1i1rA01 |
82.15 |
Jak-STAT signaling pathwayOncostatin-M receptor complexResponse to cytokine stimulusPositive regulation of osteoblast differentiationPositive regulation of tyrosine phosphorylation of Stat1 protein |
2.60.40.10 |
100 |
6 |
82 |
2.44 |
2.96 |
 |
3k3qA00 |
82.07 |
|
2.60.40.10 |
137 |
21 |
75 |
2.70 |
3.59 |
 |
1iamA02 |
82.04 |
Leukocyte migrationAdhesion to symbiontHeterophilic cell-cell adhesionRegulation of leukocyte mediated cytotoxicityT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
2.60.40.10 |
102 |
5 |
81 |
2.33 |
2.86 |
 |
2dm2A00 |
81.99 |
NucleusHomo sapiensPalladinActin filamentMuscle alpha-actinin binding |
2.60.40.10 |
110 |
11 |
81 |
2.87 |
3.51 |
 |
1iilG02 |
81.98 |
Cell surfacePathways in cancerNucleusPositive regulation of cell proliferationFibroblast growth factor binding |
2.60.40.10 |
107 |
12 |
79 |
3.36 |
4.23 |
 |
1zxqA02 |
81.93 |
Intercellular adhesion molecule 2Integral to plasma membraneIntercellular adhesion molecule 2Natural killer cell mediated cytotoxicityHomo sapiens |
2.60.40.10 |
107 |
9 |
81 |
3.04 |
3.74 |
 |
2fcbA02 |
81.77 |
Low affinity immunoglobulin gamma Fc region receptor II-bHomo sapiensImmune responseSignal transduction |
2.60.40.10 |
87 |
9 |
76 |
3.32 |
4.33 |
 |
1dqtA00 |
81.75 |
Mus musculusExternal side of plasma membraneCytotoxic T-lymphocyte protein 4 |
2.60.40.10 |
117 |
18 |
84 |
3.32 |
3.92 |
 |
2gy5A04 |
81.69 |
MicrovillusCell surfaceTransmembrane receptor protein tyrosine kinase signaling pathwaySignal transductionProtein binding |
2.60.40.10 |
99 |
8 |
81 |
2.75 |
3.37 |
 |
2g5rA00 |
81.67 |
Sialic acid-binding Ig-like lectin 7Sialic acid binding Ig-like lectin 7Receptor activityIntegral to plasma membraneHomo sapiens |
2.60.40.10 |
113 |
13 |
86 |
4.29 |
4.95 |
 |
1waaC00 |
81.63 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
93 |
7 |
79 |
3.39 |
4.26 |
 |
1itbB03 |
81.55 |
Platelet-derived growth factor receptor bindingIntegral to plasma membraneHematopoietic cell lineageInterleukin 1 receptor, type IInterleukin-1-mediated signaling pathway |
2.60.40.10 |
112 |
11 |
80 |
2.74 |
3.41 |
 |
1nkrA02 |
81.46 |
Receptor activityIntegral to plasma membraneHomo sapiensImmune responseNatural killer cell inhibitory signaling pathway |
2.60.40.10 |
98 |
7 |
81 |
3.05 |
3.74 |
 |
1f2qA02 |
81.39 |
High affinity immunoglobulin epsilon receptor subunit alphaIntegral to plasma membraneHomo sapiensFc receptor, IgE, high affinity I, alpha polypeptideAsthma |
2.60.40.10 |
90 |
8 |
77 |
3.77 |
4.85 |
 |
3bfoA00 |
81.27 |
T cell receptor signaling pathwayPositive regulation of T cell cytokine productionActivation of NF-kappaB-inducing kinase activityPositive regulation of interleukin-2 productionNucleus |
2.60.40.10 |
85 |
9 |
72 |
2.37 |
3.25 |
 |
1t0pB00 |
80.77 |
Integral to plasma membraneIntercellular adhesion molecule 3Homo sapiensIntercellular adhesion molecule 3Cell adhesion molecules (CAMs) |
2.60.40.10 |
86 |
10 |
77 |
3.01 |
3.88 |
 |
1iamA01 |
80.53 |
Leukocyte migrationAdhesion to symbiontHeterophilic cell-cell adhesionRegulation of leukocyte mediated cytotoxicityT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
2.60.40.10 |
83 |
10 |
77 |
3.34 |
4.30 |
 |
1hzhH01 |
80.53 |
|
2.60.40.10 |
119 |
18 |
68 |
2.60 |
3.82 |
 |
1rhfA02 |
80.44 |
Integral to plasma membraneTyrosine-protein kinase receptor TYRO3Cell adhesionTYRO3 protein tyrosine kinase 3 [EC:2.7.10.1]Signal transduction |
2.60.40.10 |
84 |
10 |
77 |
2.67 |
3.44 |
 |
2fcbA01 |
80.41 |
Low affinity immunoglobulin gamma Fc region receptor II-bHomo sapiensImmune responseSignal transduction |
2.60.40.10 |
86 |
9 |
71 |
3.33 |
4.63 |
 |
1bihA02 |
80.23 |
Hyalophora cecropiaHemolin |
2.60.40.10 |
106 |
12 |
83 |
3.01 |
3.63 |
 |
1ugnA01 |
80.17 |
Homo sapiensLeukocyte immunoglobulin-like receptor subfamily B member 1Integral to membraneResponse to virusProtein phosphatase 1 binding |
2.60.40.10 |
95 |
9 |
82 |
3.83 |
4.64 |
 |
1fltX00 |
80.15 |
Vascular endothelial growth factor receptor 1Integral to plasma membraneGrowth factor bindingVascular endothelial growth factor receptor activityFemale pregnancy |
2.60.40.10 |
95 |
9 |
82 |
3.38 |
4.10 |
 |
1q0xL02 |
80.09 |
Mus musculusIg lambda-1 chain V regionProtein binding |
2.60.40.10 |
100 |
12 |
77 |
3.06 |
3.94 |
 |
2ec8A01 |
80.04 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Acute myeloid leukemiaProtein binding |
2.60.40.10 |
92 |
10 |
69 |
3.36 |
4.81 |
 |
1p53A01 |
80.00 |
Leukocyte migrationAdhesion to symbiontHeterophilic cell-cell adhesionRegulation of leukocyte mediated cytotoxicityT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
2.60.40.10 |
98 |
3 |
80 |
2.98 |
3.70 |
 |
1nkrA01 |
79.79 |
Integral to plasma membraneReceptor activityHomo sapiensNatural killer cell inhibitory signaling pathwayImmune response |
2.60.40.10 |
97 |
7 |
82 |
3.83 |
4.64 |
 |
3b4nA01 |
79.78 |
Erwinia chrysanthemiEndo-pectate lyase |
2.60.40.10 |
88 |
4 |
78 |
3.20 |
4.07 |
 |
1n26A02 |
79.66 |
Positive regulation of chemokine productionPositive regulation of smooth muscle cell proliferationJak-STAT signaling pathwayAcute-phase responsePositive regulation of osteoblast differentiation |
2.60.40.10 |
78 |
16 |
68 |
3.40 |
4.93 |
 |
1pd6A00 |
79.63 |
Myosin-binding protein C, cardiac-typeHomo sapiensVentricular cardiac muscle tissue morphogenesisStriated muscle myosin thick filamentStructural constituent of muscle |
2.60.40.10 |
94 |
10 |
80 |
3.06 |
3.80 |
 |
1v05A00 |
79.62 |
Plasma membraneFilamin-CHomo sapiens |
2.60.40.10 |
96 |
6 |
80 |
3.95 |
4.90 |
 |
1o0vA01 |
79.41 |
Homo sapiensIg epsilon chain C region |
2.60.40.10 |
102 |
12 |
80 |
3.62 |
4.49 |
 |
2nqcA00 |
79.37 |
Plasma membraneFilamin-CHomo sapiens |
2.60.40.10 |
97 |
6 |
79 |
3.93 |
4.94 |
 |
1uvqA02 |
79.36 |
|
2.60.40.10 |
99 |
10 |
77 |
3.31 |
4.26 |
 |
3cmgA04 |
79.02 |
Putative beta-galactosidaseBacteroides fragilis NCTC 9343 |
2.60.40.1560 |
87 |
4 |
74 |
2.95 |
3.95 |
 |
1edqA01 |
78.99 |
Chitinase ASerratia marcescens |
2.60.40.10 |
107 |
5 |
75 |
3.29 |
4.35 |
 |
2gy5A01 |
78.95 |
Cell surfaceMicrovillusIntegral to plasma membraneTransmembrane receptor protein tyrosine kinase signaling pathwaySignal transduction |
2.60.40.10 |
99 |
4 |
85 |
3.76 |
4.40 |
 |
3dbxA02 |
78.83 |
CD1-2 antigenGallus gallus |
2.60.40.10 |
99 |
8 |
78 |
3.53 |
4.49 |
 |
1nctA00 |
78.78 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
98 |
16 |
84 |
3.02 |
3.58 |
 |
3h9yA02 |
78.57 |
Homo sapiensIg epsilon chain C region |
2.60.40.10 |
108 |
6 |
75 |
3.46 |
4.56 |
 |
1ow0A02 |
78.55 |
Homo sapiensProtein bindingIg alpha-1 chain C region |
2.60.40.10 |
109 |
10 |
74 |
3.04 |
4.09 |
 |
1mcpH02 |
78.29 |
Mus musculusIg heavy chain V region M603 |
2.60.40.10 |
99 |
13 |
76 |
3.61 |
4.71 |
 |
3b9eA01 |
78.22 |
Vibrio harveyiChitinase A |
2.60.40.10 |
110 |
3 |
73 |
3.25 |
4.41 |
 |
1l6xA02 |
78.22 |
Ig gamma-1 chain C regionHomo sapiensProtein bindingAntigen binding |
2.60.40.10 |
106 |
10 |
74 |
3.45 |
4.63 |
 |
2bc4A02 |
78.02 |
HLA class II histocompatibility antigen, DM alpha chainHomo sapiensProtein binding |
2.60.40.10 |
109 |
8 |
77 |
3.88 |
4.98 |
 |
1itbB01 |
78.02 |
Platelet-derived growth factor receptor bindingIntegral to plasma membraneHematopoietic cell lineageInterleukin 1 receptor, type IInterleukin-1-mediated signaling pathway |
2.60.40.10 |
92 |
15 |
83 |
3.99 |
4.78 |
 |
2nziA03 |
78.01 |
Structural constituent of muscleCalcium ion bindingSarcomere organizationTelethonin bindingActin filament binding |
2.60.40.10 |
94 |
3 |
81 |
3.98 |
4.88 |
 |
1l6xA01 |
78.00 |
Ig gamma-1 chain C regionHomo sapiensProtein bindingAntigen binding |
2.60.40.10 |
100 |
9 |
76 |
3.27 |
4.26 |
 |
1ej6A05 |
77.99 |
Mammalian orthoreovirus 3 DearingOuter capsid protein lambda-2 |
2.60.40.10 |
95 |
8 |
86 |
4.29 |
4.96 |
 |
1cfbA01 |
77.88 |
Calcium ion bindingNeuron cell-cell adhesionNerve maturationDrosophila melanogasterEpidermal growth factor receptor signaling pathway |
2.60.40.10 |
99 |
5 |
81 |
3.45 |
4.23 |
 |
1hxmB02 |
77.83 |
Homo sapiensT-cell receptor gamma-2 chain C region |
2.60.40.10 |
105 |
10 |
78 |
3.44 |
4.40 |
 |
1f00I01 |
77.80 |
Pathogenic Escherichia coli infectionIntiminIntiminProtein bindingEscherichia coli O127:H6 str. E2348/69 |
2.60.40.920 |
95 |
7 |
71 |
3.05 |
4.25 |
 |
1cwvA02 |
77.79 |
InvasinYersinia pseudotuberculosis |
2.60.40.920 |
97 |
3 |
78 |
3.78 |
4.81 |
 |
1u2cA01 |
77.65 |
Epithelial tube branching involved in lung morphogenesisDilated cardiomyopathyECM-receptor interactionHypertrophic cardiomyopathy (HCM)Sarcolemma |
2.60.40.10 |
103 |
9 |
80 |
3.32 |
4.12 |
 |
3fruA02 |
77.57 |
IgG receptor FcRn large subunit p51Beta-2-microglobulin bindingRattus norvegicusHumoral immune responseIgG receptor activity |
2.60.40.10 |
92 |
7 |
73 |
3.50 |
4.74 |
 |
1ut9A01 |
77.56 |
Clostridium thermocellumCellobiohydrolase |
2.60.40.10 |
98 |
2 |
78 |
3.67 |
4.67 |
 |
1cczA02 |
77.54 |
Homo sapiensLymphocyte function-associated antigen 3Protein binding |
2.60.40.10 |
78 |
8 |
71 |
3.48 |
4.84 |
 |
1dr9A02 |
77.41 |
Type I diabetes mellitusIntestinal immune network for IgA productionAutoimmune thyroid diseaseAllograft rejectionT-lymphocyte activation antigen CD80 |
2.60.40.10 |
95 |
10 |
80 |
3.64 |
4.52 |
 |
1im3D00 |
77.26 |
Unique short US2 glycoproteinHuman herpesvirus 5 strain AD169 |
2.60.40.1200 |
95 |
2 |
81 |
3.85 |
4.72 |
 |
1l0qA02 |
77.17 |
Methanosarcina mazeiORF492 |
2.60.40.670 |
90 |
8 |
71 |
3.41 |
4.75 |
 |
1axiB02 |
77.10 |
Jak-STAT signaling pathwayCell surfaceMulticellular organismal metabolic processGrowth hormone receptor complexInsulin-like growth factor receptor signaling pathway |
2.60.40.10 |
101 |
5 |
75 |
3.76 |
4.97 |
 |
1dn0D02 |
76.62 |
|
2.60.40.10 |
94 |
10 |
71 |
3.34 |
4.65 |
 |
1y6kR01 |
76.49 |
Interleukin-10 receptor activityPlasma membraneHomo sapiensInterleukin-10 receptor subunit alpha |
2.60.40.10 |
102 |
5 |
79 |
3.96 |
4.97 |
 |
1bquA01 |
76.46 |
Oncostatin-M receptor complexJak-STAT signaling pathwayResponse to cytokine stimulusPositive regulation of tyrosine phosphorylation of Stat1 proteinPositive regulation of osteoblast differentiation |
2.60.40.10 |
100 |
5 |
83 |
4.07 |
4.87 |
 |
1f6fB02 |
76.36 |
Rattus norvegicusProlactin receptorProlactin receptor activity |
2.60.40.10 |
97 |
3 |
77 |
3.74 |
4.82 |
 |
1n26A03 |
76.35 |
Positive regulation of chemokine productionJak-STAT signaling pathwayPositive regulation of smooth muscle cell proliferationResponse to cytokine stimulusAcute-phase response |
2.60.40.10 |
104 |
4 |
77 |
3.79 |
4.87 |
 |
1ujtA00 |
76.20 |
LuteolysisPositive regulation of axonogenesisCell surfaceIdentical protein bindingHomophilic cell adhesion |
2.60.40.10 |
120 |
4 |
70 |
3.40 |
4.86 |
 |
1iarB02 |
76.03 |
Jak-STAT signaling pathwayInterleukin 4 receptorIntegral to plasma membraneReceptor signaling protein activityHematopoietic cell lineage |
2.60.40.10 |
92 |
6 |
66 |
2.76 |
4.18 |
 |
1cd9B02 |
75.90 |
Mus musculusGranulocyte colony-stimulating factor receptorNeutrophil chemotaxis |
2.60.40.10 |
98 |
6 |
80 |
3.83 |
4.75 |
 |
1qg3A01 |
75.89 |
Homo sapiensIntegrin beta-4Protein bindingIntegrin complex |
2.60.40.10 |
91 |
10 |
80 |
3.95 |
4.90 |
 |
2ec8A02 |
75.88 |
Pathways in cancerHematopoietic cell lineageProto-oncogene tyrosine-protein kinase Kit [EC:2.7.10.1]Acute myeloid leukemiaProtein binding |
2.60.40.10 |
87 |
9 |
80 |
3.59 |
4.46 |
 |
1fnfA03 |
75.83 |
FibronectinPeptide cross-linkingER-Golgi intermediate compartmentFibrinogen complexSubstrate adhesion-dependent cell spreading |
2.60.40.10 |
89 |
1 |
81 |
3.96 |
4.86 |
 |
3k2mC00 |
75.75 |
|
2.60.40.10 |
101 |
5 |
81 |
3.89 |
4.77 |
 |
2mcmA00 |
75.73 |
MacromomycinStreptomyces macromomyceticus |
2.60.40.230 |
112 |
9 |
74 |
3.23 |
4.36 |
 |
1qg3A02 |
75.72 |
Homo sapiensIntegrin beta-4Protein bindingIntegrin complex |
2.60.40.10 |
104 |
5 |
83 |
3.92 |
4.69 |
 |
2rb8A00 |
75.71 |
TenascinCell adhesionSyndecan bindingECM-receptor interactionTenascin |
2.60.40.10 |
93 |
6 |
75 |
3.57 |
4.71 |
 |
1k3iA03 |
75.50 |
Gibberella zeaeGalactose oxidase |
2.60.40.10 |
97 |
6 |
79 |
3.97 |
4.99 |
 |
3g08A02 |
75.47 |
Antigen-presenting glycoprotein CD1d1Endogenous lipid antigen bindingPositive thymic T cell selectionAntigen processing and presentation, exogenous lipid antigen via MHC class IbProtein binding |
2.60.40.10 |
88 |
7 |
68 |
3.38 |
4.90 |
 |
1j8kA00 |
75.22 |
FibronectinPeptide cross-linkingER-Golgi intermediate compartmentFibrinogen complexSubstrate adhesion-dependent cell spreading |
2.60.40.10 |
94 |
4 |
84 |
4.12 |
4.88 |
 |
1n6uA02 |
75.14 |
JAK-STAT cascadeIntegral to plasma membraneType I interferon receptor activityHomo sapiensResponse to virus |
2.60.40.10 |
106 |
4 |
81 |
3.93 |
4.84 |
 |
1gsmA02 |
75.07 |
Membrane fractionMucosal vascular addressin cell adhesion molecule 1Intestinal immune network for IgA productionCell adhesionHomo sapiens |
2.60.40.10 |
116 |
6 |
72 |
2.91 |
4.02 |
 |
3bgaA04 |
74.80 |
Galactose metabolismBacteroides thetaiotaomicronBeta-galactosidaseSphingolipid metabolismBeta-galactosidase [EC:3.2.1.23] |
2.60.40.320 |
105 |
5 |
79 |
3.85 |
4.87 |
 |
2fnbA00 |
74.79 |
FibronectinPeptide cross-linkingER-Golgi intermediate compartmentFibrinogen complexSubstrate adhesion-dependent cell spreading |
2.60.40.10 |
95 |
7 |
83 |
4.15 |
4.97 |
 |
1tdqA02 |
73.75 |
Nervous system developmentRattus norvegicusTenascinFocal adhesionProteinaceous extracellular matrix |
2.60.40.10 |
90 |
1 |
84 |
4.07 |
4.82 |
 |
1ok8A04 |
72.97 |
Dengue virus 2 Puerto Rico/PR159-S1/1969Genome polyprotein |
2.60.40.350 |
100 |
9 |
82 |
4.04 |
4.90 |
 |
2dtgE06 |
72.60 |
Insulin receptorInsulin receptor complexPositive regulation of nitric oxide biosynthetic processPhosphoinositide 3-kinase bindingPositive regulation of respiratory burst |
2.60.40.10 |
103 |
5 |
83 |
4.13 |
4.95 |